2-(4-ethyl-6-methylpyrazolo[1,5-a]pyrazin-2-yl)-9-methyl-7-piperidin-4-yl-1,9a-dihydropyrido[1,2-a]pyrimidin-4-one
C23H28N6O — CID 155518638
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-ethyl-6-methylpyrazolo[1,5-a]pyrazin-2-yl)-9-methyl-7-piperidin-4-yl-1,9a-dihydropyrido[1,2-a]pyrimidin-4-one
2-(4-ethyl-6-methylpyrazolo[1,5-a]pyrazin-2-yl)-9-methyl-7-piperidin-4-yl-1,9a-dihydropyrido[1,2-a]pyrimidin-4-one (PubChem CID 155518638) has the molecular formula C23H28N6O and a molecular weight of 404.52 g/mol. Its IUPAC name is 2-(4-ethyl-6-methylpyrazolo[1,5-a]pyrazin-2-yl)-9-methyl-7-piperidin-4-yl-1,9a-dihydropyrido[1,2-a]pyrimidin-4-one.
Molecular Properties
| Compound Name | 2-(4-ethyl-6-methylpyrazolo[1,5-a]pyrazin-2-yl)-9-methyl-7-piperidin-4-yl-1,9a-dihydropyrido[1,2-a]pyrimidin-4-one |
|---|---|
| PubChem CID | 155518638 |
| Molecular Formula | C23H28N6O |
| Molecular Weight | 404.52 g/mol |
| Exact Mass | 404.23 |
| IUPAC Name | 2-(4-ethyl-6-methylpyrazolo[1,5-a]pyrazin-2-yl)-9-methyl-7-piperidin-4-yl-1,9a-dihydropyrido[1,2-a]pyrimidin-4-one |
| SMILES | CCc1nc(C)cn2nc(C3=CC(=O)N4C=C(C5CCNCC5)C=C(C)C4N3)cc12 |
| InChI | InChI=1S/C23H28N6O/c1-4-18-21-10-20(27-29(21)12-15(3)25-18)19-11-22(30)28-13-17(9-14(2)23(28)26-19)16-5-7-24-8-6-16/h9-13,16,23-24,26H,4-8H2,1-3H3 |
| InChIKey | IRGHULCTBPRHPM-UHFFFAOYSA-N |
| XLogP | 2.54 |
| TPSA | 74.56 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 404.52 |
| LogP ≤ 5 | 2.54 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155518638 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.